Filing metadata

Accession number
0001209191-23-037096
Form type
Form 4
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Jun 14, 2023
Reporting period
Jun 14, 2023
Description
Insider transaction

Explore SEC Filings Hub